Back
Corporate News
Vivanza Biosciences confirms no new public funding is needed, per BSE filing
08-Aug-2026, 12:37
Vivanza Biosciences Limited informed the BSE Limited on August 8, 2026, that the company has not raised any further funds through a public issue, rights issue, or preferential issue, and therefore, the statement of deviation or variation under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable.
Vivanza Biosciences Limited informed the BSE Limited on August 8, 2026, that the company has not raised any further funds through a public issue, rights issue, or preferential issue, and therefore, the statement of deviation or variation under SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 is not applicable.